HK1062404A1 - Orodispersible effervescent tablets - Google Patents

Orodispersible effervescent tablets

Info

Publication number
HK1062404A1
HK1062404A1 HK04104960.4A HK04104960A HK1062404A1 HK 1062404 A1 HK1062404 A1 HK 1062404A1 HK 04104960 A HK04104960 A HK 04104960A HK 1062404 A1 HK1062404 A1 HK 1062404A1
Authority
HK
Hong Kong
Prior art keywords
agent
seconds
optionally
mixture
disintegrating
Prior art date
Application number
HK04104960.4A
Other languages
English (en)
Inventor
Pascal Delmas
Jean-Marc Zuccarelli
Claire Mallard
James W Mcginity
Original Assignee
Ethypharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Sa filed Critical Ethypharm Sa
Publication of HK1062404A1 publication Critical patent/HK1062404A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Non-Alcoholic Beverages (AREA)
HK04104960.4A 2001-04-20 2004-07-08 Orodispersible effervescent tablets HK1062404A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0105389A FR2823668B1 (fr) 2001-04-20 2001-04-20 Comprimes effervescents orodispersibles
PCT/FR2002/001321 WO2002085336A1 (fr) 2001-04-20 2002-04-17 Comprimes effervescents orodispersibles

Publications (1)

Publication Number Publication Date
HK1062404A1 true HK1062404A1 (en) 2004-11-05

Family

ID=8862540

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04104960.4A HK1062404A1 (en) 2001-04-20 2004-07-08 Orodispersible effervescent tablets

Country Status (15)

Country Link
US (1) US20040265380A1 (xx)
EP (1) EP1379222B1 (xx)
JP (1) JP2004525976A (xx)
CN (1) CN1633282A (xx)
AT (1) ATE416759T1 (xx)
CA (1) CA2444506C (xx)
CY (1) CY1108873T1 (xx)
DE (1) DE60230249D1 (xx)
DK (1) DK1379222T3 (xx)
ES (1) ES2319266T3 (xx)
FR (1) FR2823668B1 (xx)
HK (1) HK1062404A1 (xx)
MX (1) MXPA03009587A (xx)
PT (1) PT1379222E (xx)
WO (1) WO2002085336A1 (xx)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible
US20030228370A1 (en) * 2002-06-11 2003-12-11 Michel Serpelloni Orodispersible solid pharmaceutical form
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US8802139B2 (en) * 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US8545881B2 (en) 2004-04-19 2013-10-01 Eurand Pharmaceuticals, Ltd. Orally disintegrating tablets and methods of manufacture
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US20060039971A1 (en) * 2004-08-19 2006-02-23 Lee Robert E Effervescent composition including alternative hormone replacement therapy agent
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ589750A (en) 2004-10-21 2012-07-27 Aptalis Pharmatech Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
JP2006182679A (ja) * 2004-12-27 2006-07-13 Daicho Kikaku:Kk ストレス性胃炎予防・治療剤
DE102005009240A1 (de) 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
CA2612917A1 (en) * 2005-06-23 2007-01-04 Schering Corporation Rapidly absorbing oral formulations of pde5 inhibitors
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
PE20070698A1 (es) * 2005-11-14 2007-08-17 Teijin Pharma Ltd Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
WO2007112581A1 (en) 2006-04-03 2007-10-11 Isa Odidi Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
EP1902708A1 (de) 2006-09-25 2008-03-26 Losan Pharma GmbH Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung
CN101938984A (zh) * 2008-02-08 2011-01-05 高露洁-棕榄公司 清洁用组合物和方法
FR2938431B1 (fr) 2008-11-14 2013-12-20 Debregeas Et Associes Pharma Nouvelle composition a base d'acide gamma-hydroxybutyrique
PL387415A1 (pl) * 2009-03-06 2010-09-13 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Kompozycja farmaceutyczna zawierająca celekoksyb oraz sposób jej wytwarzania
WO2010119490A1 (ja) * 2009-04-14 2010-10-21 パナソニック株式会社 映像表示装置、映像視聴用眼鏡及び映像表示装置と映像視聴用眼鏡を備えるシステム
EP2440210A4 (en) 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
FR2949061B1 (fr) 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
FR2949062B1 (fr) 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
ES2668203T3 (es) 2009-12-02 2018-05-17 Adare Pharmaceuticals S.R.L. Microcápsulas de fexofenadina y composiciones que las contienen
WO2011101734A2 (en) 2010-02-22 2011-08-25 Lupin Limited Taste-masked powder for suspension compositions of methylprednisolone
WO2014027981A2 (en) * 2012-08-17 2014-02-20 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Effervescent tablet formulations of dapoxetine and a pde5 inhibitor
WO2014027982A2 (en) * 2012-08-17 2014-02-20 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Novel effervescent sachet formulations of dapoxetine and a pde5 inhibitor
FR3013221B1 (fr) * 2013-11-19 2020-11-27 Nabil Said Composition pharmaceutique effervescente a base de sildenafil et son procede de fabrication
EP3193843A1 (en) * 2014-09-17 2017-07-26 Steerlife India Private Limited Effervescent composition and method of making it
CN104224744A (zh) * 2014-09-28 2014-12-24 严相顺 用于家蚕细菌病防治的环丙沙星泡腾片
WO2017098481A1 (en) 2015-12-12 2017-06-15 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
ES2957388T3 (es) * 2016-07-15 2024-01-18 H2 Water Tech Ltd Composición para producir agua rica en hidrógeno
GR1009573B (el) * 2018-03-28 2019-08-12 Λαμδα Φαρμακευτικα Εργαστηρια Εφαρμοσμενης Ερευνας Και Αναπτυξης Α.Ε. Αναβραζοντα φαρμακευτικα δισκια που περιλαμβανουν νατριοφωσφορικη υδροκορτιζονη
EP4366732A1 (en) * 2021-07-09 2024-05-15 US Nano Food & Drug Inc Method of production of the composition of cyclooxygenase-2 (cox-2) inhibitors
CN115843813B (zh) * 2023-02-23 2023-05-12 山东金佑星水环境科技有限公司 一种复方氯溴泡腾速溶消毒片及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991004757A1 (en) * 1989-10-02 1991-04-18 Cima Labs, Inc. Effervescent dosage form and method of administering same
WO1998006385A1 (de) * 1996-08-15 1998-02-19 Losan Pharma Gmbh Gut schluckbare orale arzneiform
US6649186B1 (en) * 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
US6071539A (en) * 1996-09-20 2000-06-06 Ethypharm, Sa Effervescent granules and methods for their preparation
DE19822036A1 (de) * 1998-05-15 1999-11-18 Bayer Ag Brausezubereitungen
US20020160048A1 (en) * 2001-02-15 2002-10-31 Karoline Bechtold-Peters Medical formulation containing a muscarinic agonist

Also Published As

Publication number Publication date
CA2444506A1 (fr) 2002-10-31
PT1379222E (pt) 2009-03-16
ATE416759T1 (de) 2008-12-15
JP2004525976A (ja) 2004-08-26
ES2319266T3 (es) 2009-05-06
CY1108873T1 (el) 2014-07-02
CA2444506C (fr) 2010-08-10
FR2823668B1 (fr) 2004-02-27
WO2002085336A1 (fr) 2002-10-31
EP1379222A1 (fr) 2004-01-14
DK1379222T3 (da) 2009-04-14
MXPA03009587A (es) 2004-12-06
CN1633282A (zh) 2005-06-29
FR2823668A1 (fr) 2002-10-25
US20040265380A1 (en) 2004-12-30
EP1379222B1 (fr) 2008-12-10
DE60230249D1 (de) 2009-01-22

Similar Documents

Publication Publication Date Title
HK1062404A1 (en) Orodispersible effervescent tablets
WO2003053417A3 (fr) Procede de fabrication d'un comprime incluant un analgesique de type morphinique et comprime obtenu
ZA991408B (en) Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent.
WO2002043719A3 (en) Composition and method for treating snoring
DK1003486T3 (da) Farmaceutisk præparat indeholdende et bruse-syre-basepar
PT893992E (pt) Formas de dosagem oral de desintegracao rapida
AP2005003318A0 (en) Pharmaceutical compositions comprising a basic respectively acidic drug coumpound, a surfactant and a physiologically tolerable watersoluble acid respectively base.
WO2002056863A3 (en) Sustained release drug delivery devices
CA2432225A1 (en) Sustained release drug delivery devices with prefabricated permeable plugs
NO20043441L (no) Orodispersibel farmasoytisk sammensetning omfattende agomelatin
EE04877B1 (et) Asendatud 3-fenl-5-alkoks-1,3,4-oksadiasol-2-oon, selle valmistamine ja kasutamine hormoontundlikku lipaasi p„rssivas ravimis ning seda sisaldav suhkurt?ve ravim
MXPA03004870A (es) Combinacion de agonistas de gaba e inhibidores de sorbitol-deshidrogenasa.
WO2004100817A3 (en) Oral care tablet
UA86751C2 (ru) Дозированная форма ибупрофена натрия
WO2005007137A3 (de) Ambroxolhaltige tabletten
MXPA03009595A (es) Uso de antagonistas del canal de sodio neuronal para control de ectoparasitos de animales homeotermicos.
MXPA04003717A (es) Tableta masticlabe que contiene lisina.
ATE258788T1 (de) Tablette
EA200400927A1 (ru) Диспергируемая во рту фармацевтическая композиция ивабрадина
WO2004071156A3 (en) Use of edible acid in fast-dispersing pharmaceutical solid dosage forms
WO2003028624A3 (en) Levothyroxine compositions and methods
DE69813846D1 (de) Geschmacksmaskierung schlecht schmeckender formulierungen
AU2002210491A1 (en) Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof
WO2004014318A3 (en) Levothyroxine compositions and methods
MX2007002781A (es) Composición farmacéutica.

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20220416